BPC 157 and Erectile Dysfunction: What the Evidence Actually Shows FDA Compliance for Peptide Therapy and BPC 157 Holt Law In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies Everything You Need to Know About the FDA Peptide Ban